Abstract
We have synthesized the first steroid hormone-MR contrast agent conjugate designed to track the cell signaling process upon binding to a gene switch system. The derivative has a high relaxivity and when tested in vitro is active as a progesterone antagonist (RU-486). By combining a transcriptional system and a noninvasive imaging technology, such as MRI, it would be a powerful tool to research the cell signaling pathway in vivo.
Original language | English (US) |
---|---|
Pages (from-to) | 13164-13166 |
Number of pages | 3 |
Journal | Journal of the American Chemical Society |
Volume | 127 |
Issue number | 38 |
DOIs | |
State | Published - Sep 28 2005 |
ASJC Scopus subject areas
- Catalysis
- General Chemistry
- Biochemistry
- Colloid and Surface Chemistry